drugset / Trial / NCT00364260
A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if using Eprex, to maintain hemoglobin within the normal range, will prevent or delay the progression of left ventricular mass growth.
Timeline
- Start
- 1997-12
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 2000 iu | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 3000 iu | Subcutaneous |